AFNET – the Atrial Fibrillation NETwork

Physicians and scientists co-operate within the AFNET. A network is formed by hospitals and doctors’ offices – reaching from GPs to university hospitals.

Atrial Fibrillation – Information for Patients

Atrial Fibrillation is the most common arrhythmia of the heart – especially in elderly people. We inform you about the current treatment options.

Research – Clinical Trials on a European Level

Several million people in Europe live with atrial fibrillation. We investigate new treatment options. Within AFNET trials scientists co-operate on a European level.

Results – for a better treatment

New findings from AFNET trials flow into the clinical routine. AFNET experts develop recommendations for the therapy of atrial fibrillation.




[23.07.2020 ] After almost a decade of successful team work we will... [read more]
[25.03.2020 ] In the light of the current pandemic the risk of the Atrial... [read more]
[03.09.2019 ] The results of the ENTRUST-AF PCI study were presented by... [read more]
[20.02.2019 ] “Management of patients with AF: New therapies and special... [read more]
[20.03.2018 ] Press release of the European Society of Cardiology (ESC)... [read more]
[01.08.2017 ] AFNET is happy to announce to have joined Twitter! From... [read more]
[30.08.2016 ] On August 27th 2016 the ESC isued a press release on new AF... [read more]
[22.06.2016 ] Atrial fibrillation (AF) is a common cause of stroke, and... [read more]
[10.06.2016 ] AFNET scientists were significantly involved. The consensus... [read more]